Check out our most popular compounded medications! Get Started
Ondansetron 8 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. These capsules are used to treat conditions such as nausea, vomiting, gastroparesis, and nausea and vomiting induced by chemotherapy or radiation.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ondansetron 8 mg Slow Release Capsules is a compounded medication specifically designed to treat nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. This medication is a serotonin 5-HT3 receptor antagonist, which works by blocking the action of serotonin, a natural substance that can trigger nausea and vomiting. The unique formulation of this medication incorporates Methocel E4M, a type of controlled-release polymer, which allows for a gradual release of the active ingredient over an extended period of time.
The slow release of Ondansetron provides sustained therapeutic effects, reducing the frequency of dosing and improving patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile. This slow release formulation allows for more consistent relief of symptoms, providing patients with a more comfortable and manageable treatment experience.
Ondansetron 8 mg Slow Release Capsules is generally well tolerated by patients, with few side effects. Common side effects may include headache, constipation, and diarrhea. However, patients should always take the medication as directed by their healthcare provider and report any side effects or concerns immediately.
The slow release formulation ensures a more consistent relief of symptoms, enhancing patient comfort and treatment adherence.
If you have any questions or require further information about Ondansetron 8 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is always ready to assist and provide the necessary guidance and support.
Ondansetron 8 mg Slow Release Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications that require a controlled and prolonged release profile.
These capsules may interact with other medications, including those used to treat mental health conditions such as depression and anxiety, as well as medications for high blood pressure, heart disease, or diabetes. It is crucial to inform your healthcare provider or pharmacist about all other medications you are currently taking. This includes over-the-counter medications, vitamins, and herbal supplements.
Ondansetron 8 mg Slow Release Capsules may also interact with certain foods, such as grapefruit, and alcohol. It is important to discuss any dietary restrictions with your healthcare provider or pharmacist before starting this medication.
This medication is primarily used to treat nausea and vomiting associated with certain medical conditions and treatments, such as chemotherapy, radiation therapy, and surgery. It may also be used to prevent nausea and vomiting in patients receiving opioid medications for pain relief. Ondansetron 8 mg Slow Release Capsules should not be used in patients with a known hypersensitivity to ondansetron or any of its components.
If you have any questions about the interactions of Ondansetron 8 mg Slow Release Capsules with other medications, foods, or dietary supplements, please consult with your healthcare provider or pharmacist.
Ondansetron 8 mg Slow Release Capsules are a specialized formulation designed to treat nausea and vomiting associated with chemotherapy, radiation therapy, surgery, and conditions such as gastroenteritis. The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for a gradual release of the active ingredient, Ondansetron, over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing and enhancing patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
When using Ondansetron 8 mg Slow Release Capsules, it is crucial to adhere to the instructions provided by your healthcare provider. The capsules are typically taken with food or milk to minimize the potential for stomach upset. Consistency in the timing of the dose is key to ensuring a steady release of the medication into the body. This consistency aids in maintaining the therapeutic effects of the medication over a longer duration.
While Ondansetron 8 mg Slow Release Capsules are generally well-tolerated, some patients may experience side effects such as headache, constipation, and dizziness. If you encounter any of these or other side effects, it is important to promptly communicate with your healthcare provider. Additionally, it is essential to inform your healthcare provider of any other medications you are currently taking, as potential interactions may occur with Ondansetron 8 mg Slow Release Capsules.
If you have any queries or concerns regarding Ondansetron 8 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist. They can provide further information on how this specific formulation works and how it can be beneficial in managing your condition.
Ondansetron 8 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to gradually release the active ingredient over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
The dosing frequency of Ondansetron 8 mg Slow Release Capsules is reduced due to its slow release formulation. However, the exact frequency will depend on your doctor's prescription. Always follow your doctor's instructions.
The active ingredient in Ondansetron 8 mg Slow Release Capsules is Ondansetron. This medication is encapsulated in a controlled-release polymer to ensure its gradual release over an extended period of time.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to gradually release the encapsulated medication over an extended period of time.
Whether you can take Ondansetron 8 mg Slow Release Capsules with other medications will depend on the specific medications in question. Always consult your doctor or pharmacist before combining medications.
If you miss a dose of Ondansetron 8 mg Slow Release Capsules, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses. Always follow your doctor's instructions.
Like all medications, Ondansetron 8 mg Slow Release Capsules can have side effects. If you experience any unusual symptoms or side effects, contact your doctor immediately.
Even if you feel better, do not stop taking Ondansetron 8 mg Slow Release Capsules without consulting your doctor. The medication is designed to be released over an extended period of time and stopping it abruptly may affect its therapeutic effects.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
